Alzheimer’s protection effect of A673T mutation may be driven by lower Aβ oligomer binding affinity

類似資料

• Sigma‐2 receptor antagonists rescue neuronal dysfunction induced by Parkinson’s patient brain‐derived α‐synuclein
  著者:: Limegrover, Colleen S., 等
  出版事項: (2021)
• Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity
  著者:: Izzo, Nicholas J., 等
  出版事項: (2014)
• Modeling the mature CNS: A predictive screening platform for neurodegenerative disease drug discovery
  著者:: LaBarbera, Kelsie Mozzoni, 等
  出版事項: (2021)
• Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits
  著者:: Izzo, Nicholas J., 等
  出版事項: (2014)
• A phase 1 clinical trial of the sigma-2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease
  著者:: Grundman, Michael, 等
  出版事項: (2019)